These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 23194486)

  • 1. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
    Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
    Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
    Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C
    Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure.
    Fudim M; Spates T; Sun JL; Kittipibul V; Testani JM; Starling RC; Tang WHW; Hernandez AF; Felker GM; O'Connor CM; Mentz RJ
    Am Heart J; 2021 Sep; 239():110-119. PubMed ID: 34052212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretic strategies in patients with acute decompensated heart failure.
    Felker GM; Lee KL; Bull DA; Redfield MM; Stevenson LW; Goldsmith SR; LeWinter MM; Deswal A; Rouleau JL; Ofili EO; Anstrom KJ; Hernandez AF; McNulty SE; Velazquez EJ; Kfoury AG; Chen HH; Givertz MM; Semigran MJ; Bart BA; Mascette AM; Braunwald E; O'Connor CM;
    N Engl J Med; 2011 Mar; 364(9):797-805. PubMed ID: 21366472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
    Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
    JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
    Allen LA; Turer AT; Dewald T; Stough WG; Cotter G; O'Connor CM
    Am J Cardiol; 2010 Jun; 105(12):1794-7. PubMed ID: 20538132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
    Ng KT; Yap JLL
    Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
    Palazzuoli A; Ruocco G; Vescovo G; Valle R; Di Somma S; Nuti R
    ESC Heart Fail; 2017 Nov; 4(4):479-486. PubMed ID: 28980452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
    Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P
    J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.
    Ferreira JP; Santos M; Almeida S; Marques I; Bettencourt P; Carvalho H
    Clin Res Cardiol; 2013 Oct; 102(10):745-53. PubMed ID: 23839288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
    De Vecchis R; Baldi C; Di Biase G
    Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.
    Frea S; Pidello S; Volpe A; Canavosio FG; Galluzzo A; Bovolo V; Camarda A; Golzio PG; D'Ascenzo F; Bergerone S; Rinaldi M; Gaita F
    Clin Res Cardiol; 2020 Apr; 109(4):417-425. PubMed ID: 31256261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic dosing in acute decompensated heart failure: lessons from DOSE.
    Campbell PT; Ryan J
    Curr Heart Fail Rep; 2012 Sep; 9(3):260-5. PubMed ID: 22699924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
    Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
    Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.